Selection of new heteromyeloma cell lines for the obtainment of human monoclonal antibodies.
Institute of Chemistry, School of Medicine, University of Brescia, Italy.
I
I
Zanella
R
R
Verardi
R
R
Negrini
L
L
Osio
A
A
Albertini
S
S
Ghielmi
D000818:Animals; D000911:Antibodies, Monoclonal / Q000096:biosynthesis* / Q000276:immunology / Q000302:isolation & purification; D001402:B-Lymphocytes / Q000166:cytology* / Q000276:immunology; D002455:Cell Division; D002459:Cell Fusion; D002461:Cell Line, Transformed / Q000187:drug effects; D002877:Chromosomes, Human; D003470:Culture Media / Q000494:pharmacology; D006510:Hepatitis B Antibodies / Q000096:biosynthesis* / Q000276:immunology / Q000302:isolation & purification; D006512:Hepatitis B Core Antigens / Q000276:immunology*; D004854:Herpesvirus 4, Human; D006801:Humans; D006822:Hybrid Cells / Q000187:drug effects / Q000473:pathology; D006825:Hybridomas / Q000187:drug effects / Q000276:immunology / Q000473:pathology*; D007041:Hypoxanthine Phosphoribosyltransferase / Q000235:genetics; D007075:Immunoglobulin M / Q000096:biosynthesis / Q000276:immunology; D051379:Mice; D009101:Multiple Myeloma / Q000473:pathology*; D010042:Ouabain / Q000494:pharmacology; D011994:Recombinant Proteins / Q000276:immunology; D012641:Selection, Genetic; D013866:Thioguanine / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000187:drug effects
D000911:Antibodies, Monoclonal; D003470:Culture Media; D006510:Hepatitis B Antibodies; D006512:Hepatitis B Core Antigens; D007075:Immunoglobulin M; D011994:Recombinant Proteins; D010042:Ouabain; D007041:Hypoxanthine Phosphoribosyltransferase; D013866:Thioguanine